MedTrace Logo

Hypercoagulability After Breast Cancer Surgery

NCT00210197 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2013-07-26

No results posted yet for this study

Summary

The risk of deep venous thrombosis after radical breast surgery is known. The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before, during and after surgery. Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively. Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin, D-dimer and the endogen thrombin potential.

Conditions

Interventions

PROCEDURE

Blood collection (pre and postoperative): plasma coagulation parameters

Sponsors & Collaborators

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Youssef KABBANI, MD · Institut Bergonié

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2006-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210197 on ClinicalTrials.gov